Thermo Fisher Scientific Inc. officer Gianluca Pettiti filed a Form 144 notice of proposed sale of 4,133 shares of common stock on November 13, 2026, through Fidelity Brokerage Services LLC on the NYSE.
Key Highlights
- Proposed sale size: 4,133 shares of Thermo Fisher Scientific common stock with an aggregate market value of $2,898,968.86, according to the filing.
- Seller and role: Gianluca Pettiti, identified as an officer of the issuer.
- Approximate sale date: November 13, 2026, via Fidelity Brokerage Services LLC.
- Shares outstanding: The filing lists 370,515,868 shares outstanding.
- Prior 3-month sale: Pettiti sold 4,133 shares on August 31, 2026, for gross proceeds of $2,539,232.54, as disclosed in the filing.
- Rule 10b5-1 plan: The filing indicates a trading plan or instruction date of June 2, 2026.
- Source of shares: Securities to be sold were acquired through restricted stock vestings from May 2022 through February 2024 (totaling 400 shares) and a stock option exercise of 3,733 shares on November 13, 2026.
Pettiti's Proposed Share Sale: Acquisition History and Plan Details
According to the Form 144 filed with the SEC on November 13, 2026, Gianluca Pettiti, an officer of Thermo Fisher Scientific Inc. (NYSE:TMO), proposed to sell 4,133 shares of the company's common stock. The filing lists the aggregate market value of the proposed sale at $2,898,968.86. The broker named in the filing is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.
The shares proposed for sale were acquired through multiple transactions. Restricted stock vestings from the issuer occurred on May 5, 2022 (69 shares), August 26, 2022 (112 shares), February 23, 2023 (52 shares), and February 23, 2024 (167 shares), all characterized as compensation. In addition, 3,733 shares were acquired through a stock option exercise from the issuer on November 13, 2026, with cash as the nature of payment.
The filing discloses that Pettiti sold 4,133 shares of common stock on August 31, 2026, generating gross proceeds of $2,539,232.54 during the prior three-month period. The notice indicates reliance on a Rule 10b5-1 trading plan or instruction with an adoption or instruction date of June 2, 2026. The filing was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Gianluca Pettiti.
What Was Disclosed
Thermo Fisher Scientific officer Gianluca Pettiti filed a Form 144 on November 13, 2026, notifying the SEC of a proposed sale of 4,133 common shares valued at approximately $2,898,968.86, with shares sourced from restricted stock vestings and a stock option exercise.



Please wait processing your request...